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Research
AbstrACt
Objective To explore men’s lived experience of advanced 
prostate cancer (PCa) and preferences for support.
Design Cross-sectional qualitative study applying open-
ended surveys and interviews conducted between June 
and November 2016. Interviews audio-recorded and 
transcribed verbatim and analysed from an interpretive 
phenomenological perspective.
setting Australia, nation-wide.
Participants 39 men diagnosed with advanced 
PCa (metastatic or castration-resistant biochemical 
progression) were surveyed with 28 men subsequently 
completing a semistructured in depth telephone interview.
results Thematic analysis of interviews identified two 
organising themes: lived experience and supportive care. 
Lived experience included six superordinate themes: 
regret about late diagnosis and treatment decisions, 
being discounted in the health system, fear/uncertainty 
about the future, acceptance of their situation, masculinity 
and treatment effects. Supportive care included five 
superordinate themes: communication, care coordination, 
accessible care, shared experience/peer support and 
involvement of their partner/family.
Conclusions Life course and the health and social context 
of PCa influence men’s experiences of advanced disease. 
Multimodal interventions integrating peer support and 
specialist nurses are needed that more closely articulate 
with men’s expressed needs.
IntrODuCtIOn
Prostate cancer (PCa) is the second most 
common cancer in men with the highest 
incidence in Australia/New Zealand and 
North America.1 Most men present with 
localised disease or disease with regional 
lymph nodes spread with the relative 5-year 
survival rate for these men exceeding 
95%.2 3 However, one in five will progress 
to metastatic disease.4 Approximately 5% of 
men are diagnosed with metastatic disease 
and the relative 5-year survival rate for these 
men is only 30%.3 5 The mainstay treatment 
for advanced PCa is androgen deprivation 
therapy (ADT) that typically is followed 
by progression to metastatic castration-re-
sistant PCa.6 Once this occurs, median 
survival is less than 2 years,7 although 
recent therapeutic advancements such as 
abiraterone acetate and enzalutamide have 
shown potential for further slowing disease 
progression8 with median survival up to 3 
years.6 The STAMPEDE9 and LATITUDE10 
trials demonstrated a survival advantage 
for the combined use of abiraterone with 
commencement of ADT; however, this 
was offset by earlier and more prolonged 
androgen suppression and a higher risk of 
grade 3–5 adverse events.
Hence, while new treatments for advanced 
PCa prolong life, this means men are living 
longer with the effects of treatment and 
disease progression including deterio-
rating bone health, pain, hot flushes, loss 
of libido, erectile dysfunction, increased 
fat mass, sarcopenia, fatigue and cogni-
tive decline.6 11 12 Men with advanced PCa 
have poorer quality of life, higher levels 
of psychological distress, increased suicide 
risk and more unmet supportive care 
needs compared with men with localised 
disease.13–16 Approximately one in four 
experience regret about treatment deci-
sions and this is associated with poorer 
quality of life and increased distress.17 In 
sum, the burden associated with advanced 
PCa is substantial and further evolving as 
new treatments emerge.
strengths and limitations of this study
 ► Extends previous research in men with ad-
vanced prostate cancer to describing how mascu-
linities, life course and the broader social and public 
health context influence support needs.
 ► Robust and transparent study method and the appli-
cation of a phenomenological approach.
 ► Valid and reliable and transferable within the 
Australian setting.
 ► Cross-sectional design is a study limitation.
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To date there is scant psychosocial or supportive 
care intervention research directly targeting men with 
advanced PCa and the one randomised trial of scale 
completed by our team failed to prove effectiveness.15 18 
Researchers in Canada and Scotland have previously 
highlighted the persisting support services gap for 
men with advanced PCa and suggested more qualita-
tive research elucidating men’s experiences is needed 
if we are to develop effective supportive care interven-
tions.19 20 Carter et al in 2011 explored the supportive 
care needs of men with advanced PCa and concluded 
that functional issues, information needs and emotional 
distress were the three domains of need that needed 
to be addressed.19 More recently, Paterson et al (2017) 
interviewed eight men with advanced PCa describing a 
broader range of challenges extending to interpersonal 
and intimacy needs.20 Both studies emphasised the 
gap in informational support for these men; however, 
neither deeply explored issues related to masculini-
ties nor the broader social and public health context 
in which this illness experience is nested.21–23 We 
sought to extend this previous work more specifically 
connecting our enquiry between men’s challenges in 
facing advanced PCa and their preferences for support 
within their social context. Accordingly, we applied an 
interpretative phenomenological approach to describe 
the lived experience of men with advanced PCa (proven 
metastatic or castration-resistant biochemical regres-
sion) and their supportive care preferences.
MethOD
study design
This study applied a cross-sectional qualitative design. 
In a first step, participants reflected on their experience 
with advanced PCa via a mail administered open-ended 
survey. These responses provided a context to inform 
development of a protocol to guide subsequent semi-
structured in-depth telephone interviews. Consistent 
with the study aim to describe men’s lived experiences 
in the context of advanced PCa, we adopted an inter-
pretative phenomenological perspective.24 25
Participants and recruitment
Participants were recruited from an existing patient 
cohort.15 In brief, this was a cohort drawn from treat-
ment centres across Australia with participants from 
five Australian states. In June 2016, we contacted men 
who had not withdrawn from the cohort and were 
not to our knowledge deceased and had consented to 
future contact (n=141). In all, 39 men returned the 
survey (28% response) and of these 28 were available 
for telephone interview between September 2016 and 
November 2016 (72% response). Similar to the cohort 
from which participants were drawn, the mean age of 
participants was 72.7 years (SD=8.5; range 58.2–94.6) 
with the majority born in Australia (75%), married 
(86%) and retired (79%); men resided across four 
Australian states. With regard to educational level, 
7 men had a college degree, 15 had a trade or tech-
nical certificate/diploma, 2 had completed senior 
high school and 4 had completed junior high school. 
Mean time since diagnosis was 7.7 years (SD=5.0; range 
2.1–22.8). Most men were treated with ADT (88%), 73% 
radiation therapy and 62% prostatectomy. Men who 
did not participate were either too unwell (n=4), had 
a hearing impairment (n=1) or did not consent (n=6). 
Table 1 reports sociodemographic characteristics and 
treatment information for each interview participant.
Data collection
Men responded to four questions in the survey about their 
PCa-related concerns: assistance or support accessed for 
Table 1 Sociodemographic characteristics and treatment 
information for participants completing an open-ended 
survey and telephone interview
Participant ID Age (years)
Time since 
diagnosis 
(years)
Received 
hormone 
treatment 
(Y/N/NR)
P3 70 8.0 Y
P5 67 NR NR
P6 90 4.2 Y
P7 69 4.3 Y
P8 69 7.0 Y
P9 69 3.9 Y
P10 86 3.2 Y
P12 72 14.4 Y
P14 67 4.0 Y
P15 71 11.5 Y
P17 95 10.3 Y
P18 75 16.0 Y
P19 78 5.4 Y
P20 69 5.8 Y
P21 70 15.1 Y
P23 79 12.0 Y
P24 72 22.8 Y
P25 61 2.7 Y
P26 76 7.8 Y
P27 64 8.1 N
P30 58 6.0 Y
P31 59 4.8 N
P32 70 4.2 Y
P33 74 6.8 Y
P34 70 6.0 N
P35 78 4.4 Y
P38 76 NR NR
P39 83 2.1 Y
N, no; NR, not reported; Y, yes.
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these concerns and from whom, other support needed 
and preferences for support for men. Thematic anal-
ysis26 of responses (MKH, KL, SKC) indicated four areas 
that were challenging for men and in which they lacked 
support: information, medical care, side-effects and 
the future. Three experienced female interviewers in a 
research fellow or research assistant position with post-
graduate training in the behavioural sciences (ML, KL, 
EE) conducted telephone interviews to further explore 
the key areas identified. Interviews were on average 
62.1 min in length (SD=19.2; range=29.2–111.9 min). 
Member checking occurred at the beginning of each 
interview during which the interviewer asked participants 
to comment on the accuracy of researcher interpretation 
of survey results and gave participants the opportunity 
to add anything they thought had been missed. Inter-
view questions (table 2) explored in greater depth the 
concerns previously identified in men’s survey responses: 
health system concerns, supportive care needs, barriers 
to support and preferred approaches. Participants were 
invited to discuss other aspects of their experience that 
they considered were important. Interviews were audio-re-
corded and transcribed verbatim.
Data analysis
Interview transcripts were analysed using thematic anal-
ysis.26 27 Themes were derived inductively from the data 
by reading and re-reading the interview narratives and 
from this developing an understanding of men’s lived 
experience through their words. Coders had social and 
behavioural science (SKC, MKH, JD, KL) and nursing 
(SKC) backgrounds with a wide range of experience from 
2 to 20 years working in psycho-oncology and PCa research 
and included male and female researchers. Transcripts 
were coded iteratively with constant comparison between 
the codes generated and the data to ensure that consistent 
and diverging responses were incorporated. Two research 
team members independently coded one-third of the 
transcripts and generated a preliminary coding scheme 
(MKH, KL). This coding scheme was further refined with 
a third (SKC) and fourth (JD) research team member. 
Once all interview transcripts were included, the coding 
scheme was further reviewed and agreed on by all coders. 
Exemplar responses were identified across transcripts to 
illustrate and confirm labelling of themes. Reporting of 
data is consistent with consolidated criteria for reporting 
qualitative studies (COREQ) guidelines.28
results
Thematic analysis identified two organising themes: lived 
experience and supportive care. The first organising 
theme reflected men’s lived experience with advanced 
PCa and within this six superordinate themes. The second 
organising theme captured elements of supportive care 
that men found challenging and their preferences for 
how care should be delivered with five superordinate 
themes. Figure 1 depicts the coding structure. Tables 3 
and 4 present illustrative quotes for each superordinate 
theme.
lived experience
Men’s lived experience with advanced PCa included six 
superordinate themes: regret about late diagnosis and 
treatment decisions, being discounted in the health 
system, fear/uncertainty about the future, acceptance 
of their situation, masculinity and treatment effects 
(table 3).
Regret about late diagnosis and treatment decisions
Most men described feeling regret about late diagnosis or 
treatment and this was commonly attributed to delays by 
clinicians. Many men perceived these delays were caused 
by general practitioners and/or specialists who would 
not perform digital rectal examinations or prostate-spe-
cific antigen (PSA) testing, did not detect PCa until it 
was well advanced despite regular testing and did not 
refer patients for further treatment or testing in a timely 
manner despite men’s requests for them to do so. From 
this, some men were left with a distrust of the medical 
Table 2 Interview questions
Focus area Question
Health system Thinking about your medical treatment, what changes do you feel would make medical services better meet the 
needs of men with advanced prostate cancer?
Supportive 
care needs
Thinking about the treatment side effects that a man with advanced prostate cancer might experience, what 
sort of support would help most?
Thinking about the future and the worries that face a man with prostate cancer that has advanced or recurred, 
what sort of support would help most?
Barriers In developing services to help men cope or manage better with advanced prostate cancer, can you describe 
support approaches or ways of helping that would not be acceptable to men? For example, supportive 
approaches that would turn men off or away?
Preferred 
approaches
In developing services to help men cope or manage better with advanced prostate cancer, can you describe 
support approaches or ways of helping that would be more attractive to men?
Other Thinking about what we have spoken about today, is there anything else we haven’t covered that you think is 
important to supporting men with advanced prostate cancer?
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profession. Many men also discussed regretting their 
treatment choices and not having had a second opinion 
so that they felt more adequately informed and clearly 
understood the outcomes of treatment, including side 
effects and how these could be managed.
Being discounted in the health system
In their interactions with clinicians, most men described 
their concerns, needs and autonomy as discounted or 
ignored. Many men felt devalued and believed they were 
somehow less important in the broader health system. 
In their experience, PCa was the ‘poor cousin’ of breast 
cancer in terms of funding, research focus and contro-
versy over the value of PSA testing and less effort by 
the government and non-profits to promote awareness 
of PCa. Some men also considered that they and their 
cancer were less important due to their older age and 
community attitudes where PCa is considered a cancer 
that may not lead to death.
Fear/uncertainty about the future
An uncertain future was discussed in terms of most men 
needing to make ‘the unknowable’ a known entity by 
understanding how much time they may have left to live, 
what lies ahead for disease progression and quality of life, 
potential treatment options and next steps for support 
when all treatment options had been exhausted. This 
information was critical to their ability to feel more in 
control and to prepare for the future both psychologically 
and practically while they were well enough to do so. By 
contrast, some men discussed not wanting to know what 
the future held in order to focus on their day-to-day life.
Acceptance
Many men used their age as a frame to accept phys-
ical changes and the threat to their mortality. Other 
approaches adopted by many men to reach accep-
tance were focusing on ‘getting on with it’, and viewing 
ongoing physical effects of the disease or its treatment 
as part of life, an inevitable outcome of treatment or 
disease progression and as a favourable alternative to 
death. Regarding sexuality, some men found changes in 
their physical capacity to have sex an ongoing cause of 
distress. Other men shifted their focus to other aspects 
of their relationships (eg, expressing intimacy in ways 
Figure 1 Coding structure derived from thematic analysis.
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 p
am
p
hl
et
 w
as
, i
f y
ou
 t
oo
k 
D
ru
g 
X
 t
ab
le
ts
, 
w
he
n 
th
ey
 s
to
p
p
ed
 w
or
ki
ng
, y
ou
 t
oo
k 
D
ru
g 
Y
 t
ab
le
ts
. W
he
n 
th
ey
 s
to
p
p
ed
 w
or
ki
ng
, t
he
 n
ex
t 
th
in
g 
on
 t
he
—
on
 t
he
 la
d
d
er
 
w
as
 d
ea
th
, d
-e
-a
-t
-h
. W
el
l, 
I’v
e 
b
ee
n 
ta
ki
ng
 D
ru
g 
X
 fo
r 
q
ui
te
 a
 w
hi
le
. I
’v
e 
b
ee
n 
ta
ki
ng
 D
ru
g 
Y
 fo
r 
q
ui
te
 a
 w
hi
le
. E
ac
h 
ha
d
 a
 
d
efi
ni
te
 e
ffe
ct
 o
n 
m
y 
P
S
A
, e
ac
h 
lo
st
 t
ha
t 
ef
fe
ct
. S
o 
re
al
ly
, t
he
 n
ex
t 
th
in
g 
th
at
 fa
ce
s 
m
e 
is
 d
ea
th
. N
ow
, s
o,
 it
 w
as
 4
 m
on
th
s 
ag
o 
th
at
 m
y 
on
co
lo
gi
st
 g
av
e 
m
e,
 h
e 
sa
id
, ‘
Y o
u’
ll 
se
e 
yo
ur
 b
irt
hd
ay
.’ 
W
el
l, 
th
at
’s
 o
nl
y 
3 
m
on
th
s 
aw
ay
, i
t’s
 o
nl
y 
2 
m
on
th
s 
aw
ay
 
ac
tu
al
ly
. W
ha
t’s
 g
oi
ng
 t
o 
ha
p
p
en
 b
et
w
ee
n 
no
w
 a
nd
 t
he
n?
” 
(P
6)
A
cc
ep
ta
nc
e
“I
 t
hi
nk
 a
cc
ep
ta
nc
e.
 T
ha
t 
w
ou
ld
 b
e 
th
e 
w
or
d
 t
ha
t 
co
m
es
 t
o 
m
in
d
. N
ot
 r
es
ig
na
tio
n,
 b
ig
 d
iff
er
en
ce
 in
 m
y 
m
in
d
 b
et
w
ee
n 
re
si
gn
at
io
n 
an
d
 a
cc
ep
ta
nc
e,
 b
ut
 o
ka
y,
 I 
ac
ce
p
t 
it,
 t
o 
liv
e 
a 
b
it 
lo
ng
er
, o
r 
fe
el
 a
 b
it 
b
et
te
r 
(e
re
ct
ile
 d
ys
fu
nc
tio
n)
. T
hi
s 
is
 w
ha
t 
ha
p
p
en
s,
 I'
ve
 ju
st
 g
ot
 t
o 
co
m
e 
to
 t
er
m
s 
w
ith
 it
 t
he
 b
es
t 
w
ay
 I 
ca
n.
 I 
d
id
n'
t 
ha
nd
le
 it
 t
oo
 w
el
l. 
I t
hi
nk
 e
ve
n 
at
 t
ha
t 
ag
e,
 y
ou
 
th
in
k 
yo
u'
re
 in
d
es
tr
uc
tib
le
. G
ee
s,
 it
 d
id
 h
ap
p
en
. B
ut
, i
t'
s 
no
t 
th
e 
en
d
 o
f t
he
 w
or
ld
 a
nd
 t
ha
t'
s 
th
e 
at
tit
ud
in
al
 p
ar
t,
 I 
th
in
k,
 m
or
e 
so
 t
ha
n—
at
tit
ud
e 
in
 r
et
ro
sp
ec
t,
 a
cc
ep
ta
nc
e 
an
d
 s
p
iri
tu
al
ity
 p
ar
t 
of
 it
…
I c
an
 p
os
si
b
ly
 li
ke
n 
it,
 s
or
t 
of
, s
om
et
hi
ng
 a
ki
n 
to
 g
rie
f 
co
un
se
lli
ng
 is
 w
ha
t 
I n
ee
d
ed
. Y
ou
 k
no
w
, t
he
re
's
 a
ng
er
, t
he
re
's
 fr
us
tr
at
io
n,
 e
ve
ry
th
in
g.
 T
he
 w
ho
le
 g
am
b
it.
 It
's
 a
ll 
th
er
e.
 It
's
 
lik
e,
 o
ka
y,
 it
's
 p
as
se
d
 a
w
ay
 n
ow
, y
ou
 k
no
w
, l
et
 it
 r
es
t…
I j
us
t 
as
su
m
ed
, p
op
 a
 c
ou
p
le
 o
f V
ia
gr
a,
 y
ou
'll
 b
e 
rig
ht
. B
ut
, n
o.
 S
o,
 
ye
ah
, i
t'
s—
ye
ah
 a
nd
 t
ha
t'
s 
a 
p
ro
b
le
m
 a
ft
er
 b
ei
ng
 v
er
y 
ac
tiv
e 
fo
r 
su
ch
 a
 lo
ng
 t
im
e 
w
ith
 a
 b
ea
ut
ifu
l w
ife
, i
t'
s 
re
al
ly
 h
ar
d
, r
ea
lly
 
ha
rd
 t
o 
ta
ke
.”
 (P
30
)
M
as
cu
lin
ity
“P
ar
tly
, I
 t
hi
nk
, t
he
 r
el
uc
ta
nc
e 
of
 m
en
 t
o 
ta
lk
 a
b
ou
t 
th
ei
r 
he
al
th
, o
r 
to
 t
al
k 
ab
ou
t 
p
er
so
na
l i
ss
ue
s 
th
at
 t
he
 id
ea
 o
f m
al
en
es
s,
 
b
ei
ng
 a
b
le
 t
o 
b
e 
st
oi
c 
an
d
 c
op
e,
 t
yp
e 
of
 t
hi
ng
. A
nd
 ju
st
 in
 t
he
 id
ea
 o
f m
al
en
es
s,
 t
ha
t,
 s
or
t 
of
, m
en
 d
on
’t 
cr
y,
 m
en
 a
re
 s
to
ic
, 
or
 y
ou
 g
et
 o
n 
an
d
 c
op
e 
w
ith
 t
hi
ng
s,
 a
 lo
t 
of
 m
en
 h
av
e 
no
t 
b
ee
n 
ex
p
os
ed
 t
o 
ta
lk
in
g 
ab
ou
t 
p
er
so
na
l m
at
te
rs
 a
nd
 s
o 
fin
d
 it
 
d
iffi
cu
lt 
to
 d
o 
th
at
.”
 (P
9)
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S
up
er
o
rd
in
at
e 
th
em
e
E
xe
m
p
la
r 
q
uo
te
s
Tr
ea
tm
en
t 
ef
fe
ct
s
“I
’m
 im
p
ot
en
t,
 a
nd
 t
ha
t—
p
ut
 it
 t
hi
s 
w
ay
, t
ha
t'
s—
ho
ne
st
ly
, t
ha
t’s
 s
om
et
hi
ng
 t
ha
t 
I h
av
e 
an
 e
xt
re
m
el
y 
ha
rd
 t
im
e 
co
m
in
g 
to
 
te
rm
s 
w
ith
. M
y 
w
ife
 a
nd
 I 
ha
d
 a
 fa
nt
as
tic
 s
ex
 li
fe
 b
ut
 t
ha
t’s
 g
on
e 
an
d
 t
he
re
's
 n
ow
—
ye
ah
, i
t’s
 p
ro
b
ab
ly
 a
s 
m
uc
h 
m
y 
fa
ul
t 
as
 
he
rs
 b
ut
 t
he
re
's
 ju
st
 n
ot
hi
ng
 le
ft
 o
f o
ur
 m
ar
ria
ge
; w
e 
liv
e 
to
ge
th
er
 b
ut
 t
ha
t’s
 a
b
ou
t 
it.
” 
(P
38
)
“I
 c
an
’t 
ev
en
 w
al
k 
d
ow
n 
th
e 
b
ea
ch
, p
ut
 o
ut
—
no
t 
ha
vi
ng
 t
o 
ur
in
at
e 
a 
co
up
le
 o
f t
im
es
, I
 t
ak
e 
m
y 
d
og
 fo
r 
a 
p
re
tt
y 
lo
ng
 w
al
k 
ea
ch
 d
ay
 a
nd
 I’
m
 lo
ok
in
g 
ov
er
 m
y 
sh
ou
ld
er
 a
nd
 I’
m
 a
lw
ay
s 
th
in
ki
ng
 o
ne
 d
ay
 I’
m
 g
oi
ng
 t
o 
ge
t 
b
us
te
d
 a
nd
 s
om
eo
ne
’s
 g
oi
ng
 
to
 c
al
l m
e 
a 
d
irt
y 
ol
d
 m
an
 a
nd
 a
re
 t
he
y 
go
in
g 
to
 e
ve
n 
b
e 
p
re
p
ar
ed
 t
o 
lis
te
n 
to
 t
he
 fa
ct
 t
ha
t 
I’v
e 
ha
d
 p
ro
st
at
e 
ca
nc
er
 a
nd
 it
's
 
no
t 
m
y 
fa
ul
t?
” 
(P
14
)
“E
at
in
g 
is
 a
 p
ro
b
le
m
, I
 h
av
e 
a 
p
ro
b
le
m
 e
at
in
g.
 I 
d
on
’t 
re
al
ly
 w
an
t 
to
 e
at
 b
ut
 I 
m
or
e 
or
 le
ss
 fo
rc
e 
m
ys
el
f t
o 
ea
t,
 b
ec
au
se
 I 
ha
ve
 n
o 
en
er
gy
, b
ut
 I’
ve
 lo
st
, I
 t
hi
nk
, i
t’s
 4
0 
ki
lo
s 
al
l t
og
et
he
r, 
b
ut
 t
ha
t’s
 o
ve
r 
a 
p
er
io
d
. W
he
n 
I l
oo
k 
in
 t
he
 m
irr
or
 I 
se
e 
th
is
 
ga
un
t 
fa
ce
 lo
ok
in
g 
at
—
I t
ho
ug
ht
 I 
w
as
 fa
irl
y 
go
od
 lo
ok
in
g 
fo
r 
an
 o
ld
 b
lo
ke
 b
ut
 n
ow
 I 
re
al
ly
 lo
ok
 b
lo
od
y 
p
ai
nf
ul
, I
 t
ak
e 
no
tic
e,
 
lik
e,
 g
od
 I’
m
 g
au
nt
. A
nd
 I 
re
al
ly
 a
m
 t
hi
n.
” 
(P
19
)
“T
he
 g
en
er
al
 fa
tig
ue
, l
os
s 
of
 e
ne
rg
y,
 lo
ss
 o
f m
us
cl
e 
to
ne
, t
he
 h
or
m
on
al
 is
su
es
 w
er
e 
p
ro
b
ab
ly
 t
he
 b
ig
ge
st
 o
ne
s.
 I’
ve
 g
ot
 
os
te
op
or
os
is
 b
ec
au
se
—
it’
s 
on
ly
 a
t 
th
e 
ea
rly
 s
ta
ge
, b
ut
 m
y 
b
on
e 
d
en
si
ty
 is
 c
he
ck
ed
 r
eg
ul
ar
ly
, b
ut
 it
’s
 d
ro
p
p
in
g 
sl
ow
ly
 e
ve
n 
th
ou
gh
 I 
d
o 
ex
er
ci
se
, w
al
k 
a 
lo
t 
an
d
 k
ee
p
 m
y 
w
ei
gh
t 
d
ow
n 
an
d
 e
xe
rc
is
es
 u
p
. I
 d
o 
th
at
 s
or
t 
of
 t
hi
ng
 a
ll 
th
e 
tim
e.
 B
ut
 I’
m
 
p
ro
b
ab
ly
 h
ol
d
in
g 
it 
in
 c
he
ck
. B
ut
 t
ha
t 
on
e’
s 
al
w
ay
s 
a 
b
it 
of
 a
 c
on
ce
rn
. I
’v
e 
go
t 
to
 b
e 
ca
re
fu
l I
 d
on
’t 
fa
ll 
of
f t
he
 r
oo
f, 
I d
on
’t 
d
o 
so
m
et
hi
ng
, d
on
’t 
b
re
ak
 a
ny
th
in
g 
no
w
ad
ay
s.
 In
 fa
ct
 I—
w
he
n 
I fi
ni
sh
ed
 r
ad
ia
tio
n 
th
er
ap
y 
I f
el
t 
al
l p
re
tt
y 
sm
ar
t 
an
d
 I 
w
en
t 
ru
nn
in
g 
on
 t
he
 r
oc
ks
 a
t 
th
e 
b
ea
ch
 o
ne
 d
ay
, a
nd
 ju
m
p
ed
 fr
om
 o
ne
 r
oc
k 
to
 a
no
th
er
, a
nd
 s
na
p
p
ed
 m
y 
an
kl
e 
so
 b
ad
ly
 it
 h
ad
 t
o 
b
e 
sc
re
w
ed
 u
p
 w
ith
 s
cr
ew
s 
an
d
 b
ra
ce
s.
” 
(P
5)
“I
 n
ow
 h
av
e 
gy
ne
co
m
as
tia
 w
hi
ch
 I’
ve
 d
is
cu
ss
ed
 w
ith
 m
y 
G
P
 a
nd
 m
y 
sp
ec
ia
lis
t.
 I 
w
as
 lo
ok
in
g 
at
 h
av
in
g 
m
y 
b
re
as
ts
 
re
m
ov
ed
, u
nf
or
tu
na
te
ly
 w
hi
ch
 I 
w
ou
ld
’v
e 
ha
d
 t
o 
p
ay
 fo
r, 
b
ut
 I 
w
as
 t
ol
d
 t
ha
t 
if 
I d
id
, t
he
y 
w
ou
ld
 c
om
e 
b
ac
k 
so
 it
 w
ou
ld
 b
e 
a 
w
as
te
 o
f t
im
e 
an
d
 e
ffo
rt
 a
nd
 m
on
ey
 d
oi
ng
 it
.”
 (P
38
)
“I
 k
no
w
 t
he
 c
an
ce
r’s
 s
p
re
ad
in
g.
 I 
w
ok
e 
up
 t
hi
s 
m
or
ni
ng
 a
b
ou
t 
4 
o’
cl
oc
k 
w
ith
 p
ai
ns
 in
 m
y 
p
el
vi
c,
 w
he
re
 it
 is
, t
he
 p
el
vi
c 
b
on
e 
w
he
re
 I 
su
sp
ec
t 
th
e 
ca
nc
er
’s
 m
ov
in
g 
to
. T
he
y 
sa
id
 it
 w
ou
ld
 a
t 
th
e 
C
an
ce
r 
C
lin
ic
, s
o 
th
at
 g
av
e 
m
e 
a 
b
it 
of
 p
ai
n.
 B
ut
 I 
fin
d
 
if 
I t
ak
e 
P
an
ad
ol
, o
ne
 o
f t
he
se
 P
an
ad
ol
s—
I t
ak
e 
tw
o 
at
 n
ig
ht
 a
nd
 t
w
o 
in
 t
he
 m
or
ni
ng
 a
nd
 t
w
o 
m
id
d
ay
, I
 k
ee
p
 t
he
 p
ai
n 
at
 a
 
le
ve
l t
ha
t’s
 q
ui
te
 a
cc
ep
ta
b
le
. B
ut
 I 
d
id
n’
t 
ta
ke
 it
 la
st
 n
ig
ht
 a
nd
 t
he
n 
I w
ok
e 
up
 a
t 
4 
o’
cl
oc
k 
an
d
 t
ho
ug
ht
, o
h,
 w
ha
t’s
 g
oi
ng
 o
n 
he
re
.”
 (P
23
)
“I
 m
ea
n 
on
e 
of
 t
he
 b
ig
ge
st
 im
p
ac
ts
 is
 fi
na
nc
ia
l l
os
s 
an
d
 t
ha
t 
is
 n
ot
 d
is
cu
ss
ed
 fu
ll 
st
op
. T
ha
t’s
 w
he
n 
yo
u’
re
 d
ia
gn
os
ed
 w
ith
 
a 
te
rm
in
al
 il
ln
es
s 
an
d
 t
he
re
 is
 n
o 
cu
re
. T
he
y 
ca
n 
sl
ow
 t
he
 d
is
ea
se
 d
ow
n,
 w
hi
ch
 t
he
y’
ve
 s
uc
ce
ss
fu
lly
 d
on
e 
in
 m
y 
ca
se
. 
B
ut
 b
ec
au
se
 o
f t
he
 s
id
e 
ef
fe
ct
 o
f l
os
s 
of
 t
es
to
st
er
on
e,
 s
o 
yo
u’
ve
 g
ot
 le
ss
 e
ne
rg
y,
 m
us
cl
e 
w
as
ta
ge
 a
nd
 a
ll 
of
 t
ha
t.
 A
nd
 t
he
 
en
d
 r
es
ul
te
d
 in
 m
e—
I h
ad
 t
o 
gi
ve
 u
p
 w
or
k.
 N
ow
, t
ha
t 
fin
an
ci
al
 lo
ss
 h
as
 b
ee
n—
m
ad
e 
a 
b
ig
 im
p
ac
t 
on
 m
y 
re
tir
em
en
t 
an
d
 
ev
er
yt
hi
ng
 e
ls
e.
” 
(P
3)
Ta
b
le
 3
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Ta
b
le
 4
 
S
up
p
or
tiv
e 
ca
re
 o
rg
an
is
in
g 
th
em
e 
an
d
 s
up
er
or
d
in
at
e 
th
em
es
S
up
er
o
rd
in
at
e 
th
em
e
E
xe
m
p
la
r 
q
uo
te
s
C
om
m
un
ic
at
io
n
“F
or
 m
e 
at
 m
y 
st
ag
e,
 o
r 
m
or
e 
ad
va
nc
ed
, o
r—
I d
on
’t 
kn
ow
 a
t 
w
ha
t 
st
ag
e 
I’m
 a
t.
 W
he
th
er
 I’
m
 a
d
va
nc
ed
 o
r 
re
as
on
ab
le
, 
or
 w
ha
t.
 I 
d
on
’t 
ha
ve
 a
ny
—
I d
on
’t 
ha
ve
 a
ny
 r
ea
l—
I d
on
’t 
kn
ow
 w
ha
t 
th
e 
sy
m
p
to
m
s 
ar
e—
if 
yo
u 
d
o 
ge
t 
ad
va
nc
ed
 o
r 
m
or
e 
ad
va
nc
ed
, I
 d
on
’t 
kn
ow
 w
ha
t 
th
e 
sy
m
p
to
m
s 
ar
e 
re
al
ly
. I
 h
av
e 
no
 in
fo
rm
at
io
n 
in
 t
ha
t 
re
ga
rd
. I
 d
on
’t 
kn
ow
.”
 (P
17
)
“H
e’
s 
no
t 
ex
ac
tly
 v
er
b
os
e,
 h
e 
d
oe
sn
’t 
sa
y 
a 
gr
ea
t 
d
ea
l. 
A
nd
 I 
go
t 
p
ut
 o
n 
D
ru
g 
Z
 a
nd
 w
as
 m
or
e 
or
 le
ss
 le
ft
 t
o 
m
y 
ow
n 
d
ev
ic
es
 w
ith
 m
y 
G
P
 w
ho
 I 
d
on
’t 
th
in
k 
he
’d
 e
ve
r 
he
ar
d
 o
f i
t 
an
d
 it
 w
as
n’
t 
re
al
ly
 u
nt
il 
ab
ou
t 
3 
or
 4
 m
on
th
s 
ag
o 
th
at
 w
e 
m
an
ag
ed
 t
o 
so
rt
 o
ut
 h
ow
 t
he
 in
je
ct
io
ns
 s
ho
ul
d
 b
e 
gi
ve
n.
” 
(P
10
)
“O
p
en
ne
ss
, I
 t
hi
nk
, f
or
 m
e 
fo
r 
th
e 
tr
ea
tm
en
t 
op
tio
ns
. P
ro
b
ab
ly
 t
he
 s
id
e 
ef
fe
ct
s 
w
er
e 
le
ss
 d
is
cu
ss
ed
 o
r 
le
ss
 p
ub
lic
is
ed
. T
he
re
 
w
as
 s
om
e,
 p
ar
tic
ul
ar
ly
 in
 t
he
 r
ad
ia
tio
n 
p
ro
ce
ss
, y
ou
 c
ou
ld
 g
et
 b
ur
ni
ng
, y
ou
 c
ou
ld
 g
et
 it
ch
in
g,
 t
hi
s,
 o
r 
th
at
, b
ut
 t
he
n 
la
te
r 
on
 
yo
u 
fin
d
 o
ut
 t
he
re
 w
as
 s
om
e 
ot
he
rs
 t
ha
t 
th
ey
 d
id
n’
t 
m
en
tio
n…
O
n 
th
at
 s
co
re
, I
 t
hi
nk
 t
he
re
’s
 s
om
e 
m
in
or
 e
xp
la
na
tio
n,
 y
ou
 w
ill
 
ge
t 
tir
ed
er
, y
ou
 w
ill
 g
et
 h
ot
 fl
us
he
s,
 b
ut
 n
o 
ad
vi
ce
—
w
ha
t 
ca
n 
yo
u 
d
o 
ab
ou
t 
a 
ho
t 
flu
sh
; g
o 
an
d
 h
av
e 
a 
co
ld
 s
ho
w
er
. T
he
re
’s
 
b
ee
n 
no
th
in
g 
on
 t
ha
t,
 a
nd
 in
 t
er
m
s 
of
 m
ay
b
e 
a 
m
ed
ic
at
io
n,
 is
 t
he
re
 s
om
et
hi
ng
 w
ill
 h
el
p
 a
s 
it 
d
oe
s 
fo
r 
la
d
ie
s,
 I’
ve
 g
ot
 n
o 
id
ea
.”
 (P
35
)
C
ar
e 
C
oo
rd
in
at
io
n
“Y
ou
 ju
st
 g
et
 t
he
 im
p
re
ss
io
n 
go
in
g 
th
ro
ug
h 
th
e 
p
ro
ce
ss
 t
ha
t 
th
e 
d
iff
er
en
t 
st
ag
es
 o
f t
he
 p
ro
ce
ss
 a
ll 
ha
ve
 t
he
ir 
ow
n 
p
eo
p
le
, 
th
ei
r 
ow
n 
se
p
ar
at
e 
te
am
 a
lto
ge
th
er
. I
 g
ue
ss
, I
 c
ou
ld
 s
um
 it
 u
p
 in
 a
 w
or
d
 a
nd
 t
ha
t’s
 c
oo
rd
in
at
io
n 
w
ith
 a
ll 
th
e 
d
iff
er
en
t 
tr
ea
tm
en
ts
 a
nd
 t
es
ts
 a
nd
 r
es
ul
ts
 a
nd
 e
ve
ry
th
in
g 
to
 d
o 
w
ith
 t
he
 t
re
at
m
en
t,
 a
ll 
th
os
e 
th
in
gs
 a
re
 t
he
re
 o
b
vi
ou
sl
y,
 p
at
ie
nt
s 
ar
e 
b
ei
ng
 t
re
at
ed
 fo
r 
a 
lo
ng
, l
on
g 
tim
e,
 b
ut
 h
av
in
g 
b
ee
n 
th
ro
ug
h 
th
e 
p
ro
ce
ss
 I 
ju
st
 fi
nd
 t
ha
t 
ev
en
 t
ho
ug
h 
yo
u 
en
d
 u
p
 g
et
tin
g 
th
ro
ug
h 
it 
it'
s 
a 
b
it 
of
 a
 m
in
efi
el
d
 fo
r 
th
e 
p
at
ie
nt
 b
ec
au
se
 t
he
y 
ha
ve
n’
t 
go
t 
a 
cl
ue
 r
ea
lly
 w
ha
t’s
 in
vo
lv
ed
, w
ha
t’s
 c
om
in
g 
ne
xt
, 
w
ha
t 
yo
u’
ve
 g
ot
 t
o 
d
o.
” 
(P
20
)
“I
t’s
 g
ot
 t
o 
b
e 
th
e 
d
oc
to
rs
. T
he
 d
oc
to
rs
, I
 t
hi
nk
, i
t 
ha
s 
to
 s
ta
rt
 a
t 
th
e 
G
P
 le
ve
l a
nd
 g
o 
rig
ht
 t
hr
ou
gh
. T
hi
s 
is
, a
s 
I s
ay
, t
hi
s 
is
 
yo
ur
 li
fe
 a
nd
 t
he
y’
re
 d
oi
ng
 t
he
 jo
ur
ne
y 
w
ith
 y
ou
. T
ha
t’s
 a
 g
oo
d
 w
ay
 o
f p
ut
tin
g 
it,
 t
he
y’
re
 d
oi
ng
 t
he
 jo
ur
ne
y 
w
ith
 y
ou
.”
 (P
15
)
“I
’d
 s
ay
 id
ea
lly
 a
t 
tim
e 
of
 d
ia
gn
os
is
, a
ft
er
 y
ou
 t
al
k 
to
 t
he
 d
oc
to
r 
th
e 
ne
xt
 s
te
p
 w
ou
ld
 b
e 
th
e 
p
ro
st
at
e 
ca
nc
er
 n
ur
se
. Y
ea
h.
 
In
to
 t
he
 t
re
at
m
en
t 
p
ar
t 
of
 it
, y
es
, a
s 
p
ar
t 
of
 t
he
 t
re
at
m
en
t 
p
ro
ce
ss
. B
ut
, i
n 
so
m
e 
w
ay
s,
 I 
th
in
k,
 t
ha
t 
if 
yo
u’
ve
 g
ot
, s
ay
, s
or
t 
of
 a
 t
ru
st
ed
 p
er
so
n,
 s
o 
if 
it’
s 
a 
p
ro
st
at
e 
ca
nc
er
 n
ur
se
 p
ro
vi
d
in
g 
go
od
 in
fo
rm
at
io
n 
an
d
 d
ire
ct
in
g 
tr
af
fic
, t
yp
e 
of
 t
hi
ng
, a
nd
 
p
ut
tin
g 
p
eo
p
le
 in
 t
ou
ch
 w
ith
 r
es
ou
rc
es
, I
 t
hi
nk
, t
ha
t’s
 p
ro
b
ab
ly
 g
oi
ng
 t
o 
he
lp
 t
o 
ov
er
co
m
e 
th
e 
d
iffi
cu
lti
es
.”
 (P
9)
“I
 t
hi
nk
 t
hi
s 
su
p
p
or
t 
id
ea
 n
ee
d
s 
to
 b
e 
b
ui
lt 
in
 a
t 
d
ia
gn
os
is
 le
ve
l i
nt
o 
th
e,
 w
el
l, 
th
e 
d
oc
to
rs
 w
ou
ld
 p
re
se
nt
 t
hi
s 
as
, “
Th
is
 is
 a
 
na
tu
ra
l p
ar
t 
of
 t
he
 t
re
at
m
en
t,
 w
e’
re
 n
ot
 s
ay
in
g 
go
 t
he
re
 if
 w
e 
th
in
k 
yo
u 
ne
ed
 it
, y
ou
 h
av
e 
b
ee
n 
d
ia
gn
os
ed
 w
ith
 c
an
ce
r, 
yo
u 
ne
ed
 it
, w
e 
w
ou
ld
 s
tr
on
gl
y 
re
co
m
m
en
d
 y
ou
 t
ak
e 
yo
ur
—
ta
ke
 t
he
 b
en
efi
t 
of
 g
oi
ng
 t
o 
a 
gr
ou
p
 fo
r,’
 I 
d
on
't
 k
no
w
 h
ow
 m
an
y 
m
ee
tin
gs
, b
ut
 a
 fe
w
. A
nd
 I 
al
so
 t
hi
nk
 t
ha
t—
ho
w
 y
ou
 d
o 
it 
I d
on
't
 k
no
w
, b
ut
 t
ha
t 
it 
ge
ts
 p
re
se
nt
ed
—
it 
is
 p
re
se
nt
ed
 t
o 
m
en
 a
s,
 
‘T
hi
s 
is
 w
ha
t 
yo
u 
d
o,
 t
he
re
 is
 n
o 
lo
ss
 o
f d
ig
ni
ty
 in
 g
oi
ng
 a
nd
 t
al
ki
ng
 o
ve
r 
yo
ur
 p
ro
b
le
m
s 
w
ith
 p
eo
p
le
 w
ho
 a
re
 in
 t
he
 s
ta
te
—
in
 
th
e 
sa
m
e 
p
os
iti
on
 a
s 
yo
u 
ar
e.
’”
 (P
39
)
A
cc
es
si
b
le
 c
ar
e
“W
el
l I
’m
 u
p
 in
 t
he
 c
ou
nt
ry
 a
nd
 w
he
n 
I g
ot
 d
ia
gn
os
ed
 t
he
re
 w
as
 r
ea
lly
 n
o 
se
rv
ic
es
 in
 m
y 
to
w
n 
an
d
 it
 w
as
 a
, y
ou
 k
no
w
 
an
 h
ou
r 
an
d
 a
 h
al
f t
rip
 t
o 
th
e 
cl
os
es
t 
p
la
ce
 w
he
re
 c
ou
ld
 g
et
 a
ny
th
in
g 
d
on
e…
W
el
l t
he
y 
ce
rt
ai
nl
y—
th
ey
 d
id
n’
t 
ev
en
 h
av
e 
ch
em
ot
he
ra
p
y 
se
rv
ic
es
 h
er
e.
 A
nd
 t
he
y 
d
id
n’
t 
ha
ve
 h
el
p
er
s 
su
ch
 a
s 
p
ro
st
at
e 
nu
rs
es
 e
tc
et
er
a,
 p
eo
p
le
 t
ha
t 
w
er
e 
sp
ec
ifi
ca
lly
 
tr
ai
ne
d
 in
 t
hi
s 
so
rt
 o
f c
an
ce
r. 
M
y 
on
co
lo
gi
st
, m
y 
ur
ol
og
is
ts
 a
re
 a
ll 
d
ow
n 
in
 M
el
b
ou
rn
e.
 I 
m
ea
n 
th
ey
’r
e 
2  
ho
ur
s 
aw
ay
 in
 a
 
m
ot
or
 c
ar
.”
 (P
34
)
“I
t’s
 a
b
ou
t 
$4
0  
00
0 
a 
ye
ar
. I
 t
hi
nk
 it
’s
 a
b
ou
t 
4 
to
 1
2,
 a
b
ou
t 
$4
00
0 
a 
m
on
th
 I 
th
in
k.
 W
hi
ch
 t
he
 m
aj
or
ity
 o
f p
eo
p
le
 c
an
’t 
af
fo
rd
 
an
yw
ay
. S
o 
he
’s
 g
ot
 a
 n
um
b
er
 o
f o
th
er
 d
ru
gs
, t
oo
. B
ut
 t
ha
t’s
 t
he
 o
ne
 h
e’
d
 li
ke
 t
o 
us
e 
ne
xt
 fo
r 
m
e.
 S
o 
w
e’
ve
 g
ot
 t
o 
d
ea
l w
ith
 
th
at
 w
he
n 
w
e 
ge
t 
th
er
e.
” 
(P
5)
“I
 d
efi
ni
te
ly
 w
ou
ld
 (g
o 
to
 a
no
th
er
 s
up
p
or
t 
gr
ou
p
). 
Th
e 
p
ro
b
le
m
 is
 I 
ca
n’
t 
d
riv
e 
an
yw
he
re
 a
t 
th
e 
m
om
en
t 
b
ec
au
se
 o
f s
om
e 
of
 
th
e 
d
ru
gs
 I’
m
 o
n;
 s
o 
it 
m
ak
es
 it
 v
er
y 
d
iffi
cu
lt 
fo
r 
m
e 
to
 g
et
 a
ny
w
he
re
. A
nd
 n
ow
 t
he
 c
lo
se
st
 g
ro
up
 o
th
er
 t
ha
n 
th
is
 o
ne
, e
ve
n 
th
at
 o
ne
 I 
ha
d
 t
o 
go
 b
y 
ca
r, 
b
ut
 t
he
 n
ex
t 
ar
ea
’s
 g
ro
up
 is
 p
ro
b
ab
ly
 a
b
ou
t 
tw
ic
e 
th
e 
d
is
ta
nc
e 
aw
ay
 a
nd
 n
ow
he
re
 n
ea
r 
p
ub
lic
 
tr
an
sp
or
t.
” 
(P
27
)
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S
up
er
o
rd
in
at
e 
th
em
e
E
xe
m
p
la
r 
q
uo
te
s
S
ha
re
d
 e
xp
er
ie
nc
e/
p
ee
r 
su
p
p
or
t
“A
nd
 I 
th
in
k 
th
at
’s
—
th
e 
b
ig
 h
el
p
 t
ha
t 
p
eo
p
le
 n
ee
d
, a
nd
 t
he
y 
ar
e 
fin
d
in
g 
it 
he
re
 b
ec
au
se
 t
he
y 
co
m
e 
to
 s
up
p
or
t 
gr
ou
p
, i
t’s
 
lo
ok
in
g 
fo
r 
so
m
e 
co
m
fo
rt
, I
 t
hi
nk
, o
r 
so
m
e 
ad
vi
ce
, o
r 
to
 t
al
k 
to
 s
om
eo
ne
 w
ho
’s
 b
ee
n 
th
er
e 
an
d
 d
on
e 
th
at
. I
 t
hi
nk
 t
ha
t 
a 
lo
t 
of
 t
ro
ub
le
 w
ith
 t
he
 G
P
s 
an
d
 t
he
 s
ur
ge
on
s,
 t
he
y—
a 
lo
t 
of
 t
he
m
 d
on
’t 
ha
ve
 t
ha
t 
fir
st
-h
an
d
 e
xp
er
ie
nc
e,
 e
ve
n 
th
ou
gh
 t
he
y 
w
or
k 
w
ith
 it
 e
ve
ry
 d
ay
 o
f t
he
ir 
liv
es
 t
he
y 
d
on
’t—
th
ey
 h
av
en
’t 
ha
d
 t
he
 a
ct
ua
l e
xp
er
ie
nc
e 
of
 li
vi
ng
 w
ith
 t
he
 d
is
ea
se
 fi
rs
t-
ha
nd
 
an
yw
ay
.”
 (P
5)
“I
 t
hi
nk
 if
 y
ou
 h
ad
 s
om
eo
ne
 o
r 
a 
lit
tle
 g
ro
up
 o
f p
eo
p
le
 w
ho
 c
ou
ld
 m
ee
t 
an
d
 t
al
k 
an
d
 h
av
e—
m
ay
b
e 
ev
en
 in
 a
 c
of
fe
e 
sh
op
, 
ha
ve
 a
 c
up
 o
f c
of
fe
e,
 e
ve
n 
th
e 
p
ub
, h
av
e 
a 
b
ee
r 
or
 c
of
fe
e 
or
 s
om
et
hi
ng
 a
nd
 d
is
cu
ss
 y
ou
r 
p
ro
b
le
m
s 
b
ec
au
se
 t
ha
t’s
 w
he
re
 
yo
u’
ll 
fin
d
 o
ut
 t
ha
t 
m
os
t 
of
 t
he
 p
eo
p
le
 h
av
e 
p
ro
b
le
m
s 
th
e 
sa
m
e 
as
 y
ou
. Y
ou
 g
et
 s
om
e 
m
en
 t
og
et
he
r, 
yo
u 
ca
n 
ha
ve
 s
om
eo
ne
 
fa
ci
lit
at
e 
it 
at
 fi
rs
t,
 t
he
n 
yo
u 
ju
st
 le
av
e 
th
em
 a
nd
 c
om
e 
b
ac
k 
la
te
r 
on
.”
 (P
19
)
“Y
ea
h,
 w
el
l f
ac
e-
to
-f
ac
e 
is
 t
he
 b
es
t 
w
ay
, b
ut
 y
ea
h,
 o
nl
in
e,
 w
hy
 n
ot
? 
P
ar
tic
ul
ar
ly
 w
ith
 p
eo
p
le
 in
 t
he
 c
ou
nt
ry
, a
ss
um
in
g 
th
ey
 
kn
ow
 h
ow
 t
o 
go
 o
nl
in
e 
an
d
 h
an
d
le
 IT
 a
nd
 a
ll 
th
at
 s
or
t 
of
 t
hi
ng
. Y
ea
h,
 s
om
eb
od
y 
or
 s
om
e 
gr
ou
p
 o
f p
eo
p
le
 t
ha
t 
th
ey
 c
an
 
co
nt
ac
t 
w
ho
 d
o 
ha
ve
 t
he
 e
xp
er
ie
nc
e 
an
d
 h
av
e 
th
e 
un
d
er
st
an
d
in
g.
” 
(P
21
)
“F
ro
m
 a
 p
er
so
na
l s
ta
nd
p
oi
nt
 o
f v
ie
w
, t
he
 n
or
m
al
 s
or
t 
of
 p
ro
st
at
e 
ca
nc
er
 s
up
p
or
t 
gr
ou
p
 h
as
n’
t 
b
ee
n 
of
 a
ny
 r
ea
l b
en
efi
t 
to
 
m
ys
el
f o
r 
m
y 
w
ife
. A
nd
 t
he
 r
ea
so
n 
ad
va
nc
ed
 p
ro
st
at
e 
ca
nc
er
 fo
r 
no
w
, b
as
ed
 in
 s
ou
th
 e
as
t 
Q
ue
en
sl
an
d
, w
hi
ch
 c
ov
er
s 
al
l o
f 
A
us
tr
al
ia
 a
nd
 w
e 
ha
ve
 a
 m
on
th
ly
 t
el
ep
ho
ne
 c
on
fe
re
nc
e 
an
d
 t
ha
t 
is
, y
ea
h 
th
at
’s
 q
ui
te
 b
en
efi
ci
al
. B
ec
au
se
 e
ve
ry
b
od
y 
in
 it
 h
as
 
go
t 
ad
va
nc
ed
 p
ro
st
at
e 
ca
nc
er
. I
t’s
 ju
st
 t
ha
t 
ye
ah
, I
’v
e 
go
t 
ad
va
nc
ed
 m
et
as
ta
tic
 p
ro
st
at
e 
ca
nc
er
 a
nd
 t
ha
t’s
 w
ha
t 
th
is
 g
ro
up
 
is
 p
ar
tic
ul
ar
 fo
r, 
fo
r 
m
en
 w
ith
 a
d
va
nc
ed
. B
ec
au
se
 w
e 
jo
ke
 a
nd
 s
ay
 w
e 
am
on
g 
ou
rs
el
ve
s,
 ‘D
ea
d
 M
en
 W
al
ki
ng
 C
lu
b
.’ 
W
ar
p
ed
 
se
ns
e 
of
 h
um
ou
r.”
 (P
3)
“A
nd
, I
 k
no
w
, I
 fo
un
d
 g
oi
ng
 t
o 
th
e 
su
p
p
or
t 
gr
ou
p
, I
 w
al
ke
d
 in
to
 t
he
 r
oo
m
, I
 s
at
 b
y 
m
ys
el
f a
nd
 I 
d
id
n’
t 
so
rt
 o
f m
ix
 w
ith
 t
he
 
ot
he
r 
m
en
, b
ut
 t
ha
t 
un
fo
rt
un
at
el
y 
is
 m
e.
 I’
m
 n
ot
 a
 m
ix
er
, I
’m
 n
ot
 a
 c
on
ve
rs
at
io
na
lis
t,
 a
lth
ou
gh
 I 
se
em
 t
o 
b
e 
ta
lk
in
g 
p
re
tt
y 
w
el
l t
o 
yo
u.
 S
o 
I f
ou
nd
 t
he
m
, i
t 
fe
lt 
a 
b
it 
un
co
m
fo
rt
ab
le
. F
or
 t
ho
se
 w
ho
 h
av
e 
b
ee
n 
th
er
e 
a 
lo
ng
 t
im
e,
 t
he
y 
w
er
e 
st
ar
tin
g 
to
 
he
ar
 t
he
 s
am
e 
th
in
g 
ov
er
 a
nd
 o
ve
r 
ag
ai
n.
 S
o 
I g
ue
ss
 t
ha
t 
m
ig
ht
 h
av
e 
b
ee
n 
w
hy
 I 
te
rm
in
at
ed
 g
oi
ng
, o
ne
 o
f t
he
 r
ea
so
ns
. 
Ve
ry
 w
el
l r
un
 g
ro
up
, I
 ju
st
 lo
st
, I
 fe
lt 
I w
as
 g
et
tin
g 
no
 b
en
efi
t 
ou
t 
of
 it
 a
nd
 I 
w
as
n’
t 
re
al
ly
 c
om
fo
rt
ab
le
 t
he
re
. T
ha
t’s
 m
e,
 m
y 
p
ar
tic
ul
ar
 m
ak
eu
p
 y
ou
 c
an
 u
nd
er
st
an
d
.”
 (P
6)
In
vo
lv
em
en
t 
of
 p
ar
tn
er
/f
am
ily
“S
he
 (w
ife
) s
en
se
s 
m
y 
fe
el
in
gs
, m
y 
m
oo
d
s,
 a
nd
 s
he
 c
an
 t
el
l i
f I
’m
 fe
el
in
g 
a 
b
it 
ne
ga
tiv
e 
b
y 
m
y 
co
m
m
en
ts
 o
r 
m
y 
ta
lk
, o
r 
m
os
tly
 m
y 
b
od
y 
la
ng
ua
ge
. A
nd
 s
he
 d
oe
sn
’t 
b
ea
t 
ar
ou
nd
 t
he
 b
us
h,
 s
he
 ju
st
 t
el
ls
 m
e 
to
 s
na
p
 o
ut
 o
f i
t,
 o
r, 
‘P
ul
l y
ou
rs
el
f 
to
ge
th
er
,’ 
or
 ‘g
et
 y
ou
rs
el
f s
or
te
d
’. 
'W
hy
 d
on
’t 
yo
u 
d
o 
th
is
, o
r 
w
hy
 d
on
’t 
yo
u 
d
o 
th
at
?’
 S
he
 d
oe
sn
’t 
m
uc
k 
ar
ou
nd
, s
he
 r
ea
lly
 
so
ck
s 
it 
to
 m
e,
 w
hi
ch
 is
 r
ea
lly
 g
oo
d
, i
t’s
 w
ha
t 
I n
ee
d
. A
nd
 I 
kn
ow
 t
ha
t 
a 
lo
t 
of
 m
en
 s
ay
 t
he
 s
am
e 
th
in
g,
 t
he
y 
ar
e 
al
w
ay
s 
gr
at
ef
ul
 fo
r 
th
ei
r 
p
ar
tn
er
s 
in
 m
an
y,
 m
an
y 
ca
se
s,
 a
nd
 w
e 
re
al
ly
 li
ve
 a
 lo
t 
lo
ng
er
 w
ith
 g
oo
d
 w
iv
es
, I
 c
an
 a
ss
ur
e 
yo
u.
 M
y 
w
ife
 is
 
d
efi
ni
te
ly
 t
he
 p
in
na
cl
e.
 S
he
’s
 t
he
 m
ai
n 
su
p
p
or
t 
th
er
e.
” 
(P
5)
“S
o,
 I 
ge
t 
he
lp
 w
ith
 t
ra
ns
p
or
t 
an
d
 I 
ha
ve
 s
om
eo
ne
 c
om
e 
an
d
 h
el
p
 m
e 
cl
ea
n 
on
ce
 a
 fo
rt
ni
gh
t 
an
d
 t
ha
t,
 b
ut
 I 
p
ro
b
ab
ly
 n
ee
d
 
he
lp
 w
ith
 s
ho
p
p
in
g,
 b
ut
 I 
ha
ve
 fr
ie
nd
s 
w
ho
 w
ill
 g
o 
an
d
 d
o 
th
e 
sh
op
p
in
g 
or
 t
ak
e 
m
e 
sh
op
p
in
g.
 S
o,
 I’
m
 fa
irl
y 
w
el
l o
ff 
in
 t
ha
t 
re
ga
rd
. S
o,
 y
ea
h,
 it
’s
 g
oo
d
 t
o 
ha
ve
 s
om
eo
ne
 w
ho
 w
ill
 h
el
p
 y
ou
, y
ou
 d
on
’t 
w
an
t 
th
em
 m
ot
he
rin
g 
yo
u,
 b
ut
 t
ak
e 
yo
u 
an
d
 if
 I 
ne
ed
ed
 s
ho
p
p
in
g 
w
e 
w
ou
ld
 g
o 
sh
op
p
in
g 
af
te
r 
w
e’
d
 b
ee
n 
to
 t
he
 g
ym
, h
ea
vy
 s
ho
p
p
in
g,
 I 
ne
ed
 it
, a
nd
 b
rin
g 
it 
ho
m
e.
” 
(P
19
)
Ta
b
le
 4
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that do not require an erection) as a way to accept their 
situation.
Masculinities
Male values and masculinities were discussed as central to 
most men’s experience of PCa, support and coping. Many 
men believed that as a group they do not look after them-
selves, go to the doctor, ask for help or talk about their 
problems by comparison to women and have a different 
view on their health, are less prepared to discuss their 
health and gave health less attention. This reluctance to 
seek help or support or talk about their problems was 
ascribed to male values around being strong, capable, inde-
pendent/autonomous or stoic. Many men used avoidance 
as a coping approach by avoiding thinking or talking about 
their situation and covering up or ignoring side-effects or 
a need for support. Some men expressed concerns that 
there would be negative consequences socially or in their 
employment if others knew about their cancer. Privacy and 
being embarrassed talking about personal issues were also 
raised by many men. Viewing sexuality and sexual func-
tion as important to their identity as a man meant that 
some men were deeply troubled by changes in sexuality 
and believed that their relationship with their partner now 
would be negatively impacted or that it would no longer be 
possible for them to start new relationships with women.
In their perceived role as ‘the provider’ and ‘the 
protector’, some men expected to give help rather than 
receive it. Some men tried to protect their wives or their 
family by not talking about their problems and thus 
avoid worrying them. Many also adopted approaches 
to promote adjustment including being optimistic and 
‘getting on with it’, taking responsibility for their health 
and well-being (eg, remaining physically active) as well as 
an action-oriented approaches in which they identified 
and solved problems directly or sought help or support. 
In using these approaches, men saw themselves as unin-
hibited by masculine norms, which typically constrain 
help seeking. Many men devalued ‘talk’ as a way to obtain 
support and viewed psychologists as not able to provide 
the solutions they needed, also describing unfavourable 
attitudes towards support groups as an opportunity for 
self-pity or drama.
Treatment effects
All men discussed the effects of advanced PCa and its 
treatment that affected their quality of life, relation-
ships, capacity to do daily tasks and for many men were 
highly distressing. Prominent among these were physical 
effects and financial concerns. Physical effects included 
the inability to obtain an erection, lack of libido, urinary 
incontinence, changes in appearance and bodily struc-
ture including gynecomastia, weight gain, sarcopenia, 
decreased bone density, fatigue, dizziness, loss of balance, 
breathlessness, hot flushes, cognitive changes and pain. 
Some men discussed no longer being well enough to 
work and that this negatively affected their income and 
retirement plans.
supportive care
The organising theme supportive care included five 
superordinate themes: communication, care coordina-
tion, accessible care, shared experience/peer support 
and involvement of their partner/family (table 4).
Communication
Men had mixed experiences in their interactions and 
communication with health professionals. Four pivotal 
points in the care trajectory in which effective commu-
nication appeared most critical were: diagnosis, deciding 
on treatment options, treatment effects and symptom 
management and follow-up care. Many men described 
being unclear about the specifics of their diagnosis (eg, 
staging, PSA) whereas, by contrast, some men appreci-
ated the direct and honest approach adopted by their 
clinicians when communicating about the severity of their 
disease. When discussing treatment options, men desired 
more guidance and support in making a treatment deci-
sion and for options to be more clearly communicated 
so that they could better understand long-term treatment 
effects. Some men were dismayed that their general prac-
titioners (GP) or other health professionals did not seem 
to have specialised knowledge about PCa. Preferred deci-
sion support included clear, unbiased communication 
about the pros and cons of each treatment option and 
referral to other sources of information that men could 
consider in their own time.
Some men described confusion and frustration 
when they were given a treatment that they needed to 
self-administer (eg, injections) but were not effectively 
instructed in how to do this. Men commonly discussed 
health professionals’ communication about treatment 
side-effects as insufficient (eg, told about effects but not 
how to deal with them) and selective (eg, told about imme-
diate but not long-term effects) and as a consequence felt 
unprepared and isolated in their experience. Some men 
described not being listened to when they raised their 
concerns or being unable to get clear answers to ques-
tions. Some men expressed that it was up to them to find 
solutions to manage their side-effects because clinicians 
did not adequately address these.
Care coordination
For some men, regular ongoing communication with 
their clinicians was a source of support; however, other 
men felt out of touch and isolated due to the length of 
time between each consultation. GPs were important to 
some men in helping them feel connected with their care 
team. Most men discussed the need for better coordi-
nated care and information and this was focused on three 
aspects: communication between health professionals, 
having a ‘middle man’ and integrating psychosocial 
support as part of routine care.
A lack of communication between specialist clinicians 
regarding treatment and referral was discussed by many 
men as problematic. Men had mixed views as to who 
should be the central point of call for information and 
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referral. Some men believed this should be their GP; 
others suggested their urologist or oncologist. Patient 
advocates or navigators were also discussed by some men 
as an option to help streamline and clarify the diagnostic 
and treatment process. Some men discussed PCa nurses 
as being central to their care. Nurses provided informa-
tional, emotional and practical support that clarified 
men’s understanding of their situation, served as an inter-
mediary between the patient or couple and other clini-
cians and were seen as more likely to refer them to other 
beneficial services than other healthcare professionals. 
These men discussed that the best time to be connected 
with a PCa nurse was at diagnosis with continued access 
throughout treatment.
Some men identified the need to integrate psychoso-
cial support as part of routine care without relying on 
men themselves to raise emotional issues with clinicians. 
Alongside this, some men also discussed the need for 
routine referral to support groups or information about 
the existence of local groups and exercise programmes as 
helpful for weight gain and muscle wastage and managing 
feelings of loss of masculinity.
Accessible care
Many men discussed three main barriers to accessible 
care: geographic location, ill health and financial cost of 
treatment. Some men experienced difficulty accessing 
services because they resided in a regional or rural loca-
tion where services were either not available or required 
them to travel long distances with resultant cost and incon-
venience. Some men had difficulty or were prevented 
from accessing central or nearby services due to ill health 
or fatigue; and some men discussed the high financial 
cost of treatments or drugs to manage side-effects such as 
erectile dysfunction and uncertainty about how to cover 
these costs. To overcome accessibility issues, these men 
suggested use of online or telephone services for those in 
rural or regional areas or who could not access care due 
to ill health, lobbying the government to subsidise finan-
cial costs of treatment and increasing the availability of 
home-based medical care or practical assistance services.
Shared experience/peer support
The opportunity to talk to other men in the same situ-
ation was discussed by most men as a source of support 
that they had, or wished they had, an awareness of and 
access to. Three aspects of shared experience/peer 
support: benefits, delivery preferences and barriers were 
described. Shared experience was highly valued by most 
men because it allowed them to talk to someone who 
had been through the same experience, obtain informa-
tion or advice when weighing up treatment decisions or 
managing side effects, make positive upward (eg, other 
men doing well and inspiring hope for recovery) or 
downward (eg, other men are doing worse so I am ok) 
comparisons,29 gave men a safe and confidential forum to 
express their concerns and helped men to feel less alone. 
However, some men did not associate peer support or 
being connected to support groups with the concept of 
sharing mutual experiences. Rather discussed it in rela-
tion to the naturally occuring companionship with other 
men from social or sporting clubs or Men’s Sheds.
Most men proposed different delivery methods for 
peer support (eg, face-to-face, telephone or online) to 
take into account individual differences and need for 
privacy or anonymity. Both structured (eg, with a facili-
tator and an agenda) and unstructured (eg, a chat over 
coffee) methods were acceptable. Some men preferred 
shared experiences specifically for men with advanced 
disease on the basis that men with localised disease have 
different treatments and cancer-related physical effects.
Finally, despite acknowledging the benefits of shared 
experience, many men also discussed barriers to peer 
support use. These included feeling uncomfortable 
to share in a group, the difficulty of sustaining support 
groups, death of peers and the belief that support 
groups were focused only on emotional or psychological 
information.
Involvement of partner/family
In addition to shared experience, most men identified 
partners and/or family and friends as sources of support 
that contributed to their emotional and physical well-
being. For most men, female partners were their main 
source of emotional and practical support. Many men 
discussed that partners were impacted by the diagnosis 
and treatment of PCa and believed it was important to 
involve and support partners in their care. Some men 
commented that partners are often the catalyst for their 
involvement in support groups or seeking out informa-
tion/support from other sources. Broader family and 
friends were also discussed by some men as sources of 
support, often providing practical assistance.
DIsCussIOn
The present study extends previous research about the 
experience of men with advanced PCa, adding an addi-
tional level of description that provides insight into how 
health context influences men’s responses, the influence 
of life course and ways in which masculinities is expressed 
in this setting. As in previous research, difficulties with 
accessible informational support about the disease and its 
treatment were highly evident.19 20 30 That these problems 
persist and are remarkably similar in Canada,19 Scotland20 
and in our Australian data, is striking and suggests that 
globally there may be a gap in health systems’ responses 
to advanced PCa. PCa survivorship research has to date 
been underfunded by comparison to breast cancer31; a 
consensus about clinical care for advanced PCa is just 
now emerging32 and the historical and persistent debate 
about the early detection of PCa23 33 are likely contribu-
tors to this. The men’s reports in our study of PCa having 
a less favourable public profile reflect this and show how 
the broader public health and social context can have a 
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profound negative impact on an already difficult cancer 
experience.
The influence of life course in response to illness in 
terms of men’s age and the expression of masculini-
ties and masculine models of coping strongly emerged 
in this study and this has implications for the design of 
care models.34 We propose that there is a need to newly 
conceptualise and then deliver what men actually want, 
rather than starting from a first principle of revising 
services already provided that are not meeting men’s 
needs. Men underuse psychosocial support services 
after cancer compared with women with breast cancer35; 
and previous research has suggested that interventions 
promoting self-management in men with chronic diseases 
should include action oriented approaches if they are to 
be used.36 37 With regard to providers of support, men 
in the present study proposed both peer support and 
nurse specialists as preferred care providers, confirming 
previous research.38
Limitations of this study include the cross-sectional 
design. Recent qualitative research applying a prospective 
study design proposed that coping with advanced cancer 
evolves over time as symptoms progress and fluctuate.39 
Future research using a prospective case study design will 
add further depth to our understanding of men’s expe-
riences in the face of advancing PCa. As well, the men 
in our study were not newly diagnosed with advanced 
disease and so reports of their experience at the time 
of diagnosis or initial disease progression are retrospec-
tive and subject to recall bias. Strengths include a robust 
and transparent study method and the involvement of 
men across four Australian states with varied sociodemo-
graphic backgrounds such that our data can be consid-
ered broadly relevant across the Australian setting. We do 
note that our participant group was not ethnically diverse 
and so likely does not represent these experiences, that 
have been well described elsewhere.40
Based on our previous research18 41 and the present 
results we propose five key content elements for inclu-
sion in supportive care interventions with men with 
advanced PCa: decision support, treatment education 
with self-management and skills training for symptoms, 
including exercise prescription, routine screening for 
psychological distress with referral, psycho-education 
with tailored distress management strategies, communi-
cating with health professionals. Strategies to integrate 
peer support within the care team are needed. Finally, the 
PCa specialist role presents as highly acceptable to men 
and is ideally placed for supportive care delivery and care 
coordination.42
In conclusion, supportive care services for men with 
advanced PCa need to be multimodal and take into 
account the influence of life course on men’s illness expe-
rience. There is a need for the health system to prioritise 
research and development in clinical PCa care taking a 
more holistic approach than currently exists.
Correction notice This article has been corrected since it first published. In the 
Abstract, "(metastatic or castration-resistant biochemical regression)" has been 
corrected to "(metastatic or castration-resistant biochemical progression)".
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